Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages
- PMID: 361575
- PMCID: PMC422057
- DOI: 10.1128/iai.21.3.714-720.1978
Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages
Abstract
Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated mouse peritoneal macrophages was studied. Thioglycolate-activated macrophages exhibited a lower percent phagocytosis than did normal macrophages. Differences in phagocytosis could not be attributed to differences in macrophage viability, minor variations in the concentration of adherent macrophages, or a general depression in activated macrophage phagocytosis. Thioglycolate-activated macrophages required heat-labile opsonins for optimal phagocytosis of non-encapsulated cryptococci, whereas nonactivated macrophages did not require heat-labile opsonins for phagocytosis of the yeast. Both types of macrophages exhibited similar sensitivity to the phagocytosis-inhibiting properties of cryptococcal polysaccharide. The results show that depletion of heat-labile opsonins from serum or inactivation of yeast-bound, heat-labile opsonins by polysaccharide cannot account for the phagocytosis-inhibiting properties of cryptococcal polysaccharide.
Similar articles
-
Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.Infect Immun. 1981 Mar;31(3):978-84. doi: 10.1128/iai.31.3.978-984.1981. Infect Immun. 1981. PMID: 7014468 Free PMC article.
-
Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.Infect Immun. 1976 Jul;14(1):62-7. doi: 10.1128/iai.14.1.62-67.1976. Infect Immun. 1976. PMID: 780279 Free PMC article.
-
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.Infect Immun. 1980 Aug;29(2):295-300. doi: 10.1128/iai.29.2.295-300.1980. Infect Immun. 1980. PMID: 7011970 Free PMC article.
-
Role of the capsule in phagocytosis of Cryptococcus neoformans.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S436-9. doi: 10.1093/cid/10.supplement_2.s436. Rev Infect Dis. 1988. PMID: 3055212 Review.
-
Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.FEMS Immunol Med Microbiol. 2012 Mar;64(2):147-61. doi: 10.1111/j.1574-695X.2011.00871.x. FEMS Immunol Med Microbiol. 2012. PMID: 22029633 Review.
Cited by
-
Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans.Infect Immun. 2009 Aug;77(8):3450-7. doi: 10.1128/IAI.00297-09. Epub 2009 Jun 1. Infect Immun. 2009. PMID: 19487474 Free PMC article.
-
Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymer.Mycopathologia. 1984 Mar 15;85(1-2):3-7. doi: 10.1007/BF00436694. Mycopathologia. 1984. PMID: 6374462
-
In vitro binding of natural killer cells to Cryptococcus neoformans targets.Infect Immun. 1985 Oct;50(1):50-7. doi: 10.1128/iai.50.1.50-57.1985. Infect Immun. 1985. PMID: 3899938 Free PMC article.
-
Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.J Exp Med. 1981 Nov 1;154(5):1618-35. doi: 10.1084/jem.154.5.1618. J Exp Med. 1981. PMID: 7299350 Free PMC article.
-
Studies of phagocytic and killing activities of alveolar macrophages in patients with sarcoidosis.Lung. 1993;171(4):225-33. doi: 10.1007/BF00203722. Lung. 1993. PMID: 8341089
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources